Journal of Biopharmaceutical Statistics

Title Publication Date Language Citations
Bayesian methods for the design and analysis of noninferiority trials2016/02/16English16
Analytical Procedure Validation and the Quality by Design Paradigm2014/10/30English16
Response to Comments by Seaman et al. on “Analysis of Longitudinal Trials With Protocol Deviation: A Framework for Relevant, Accessible Assumptions, and Inference via Multiple Imputation,” Journal of Biopharmaceutical Statistics 23:1352–13712014/09/12English16
Estimation of the shelf-life of drugs with mixed effects models1995/01/01English16
Assessment of Equivalence Using a Concordance Correlation Coefficient in a Repeated Measurements Design2005/11/01English16
Sample Size/Power Calculations for Population Pharmacodynamic Experiments Involving Repeated-Count Measurements2010/08/11English16
Missing Data in Confirmatory Clinical Trials2009/10/21English16
Comparison of treatments in a combination therapy trial1991/01/01English16
Methods of Robust Design of Nonlinear Models with an Application to Pharmacokinetics2010/05/19English16
Missing data in clinical trials for weight management2015/09/29English16
A Statistical Assessment of QT Data Following Placebo and Moxifloxacin Dosing in Thorough QT Studies2008/05/08English16
Enhancing Trial Integrity by Protecting the Independence of Data Monitoring Committees in Clinical Trials2014/08/11English16
Biosimilar Medicines—New Challenges for a New Class of Medicine2009/12/31English16
Practical Issues in Building Risk-Predicting Models for Complex Diseases2010/03/19English16
Nine-year change in statistical design, profile, and success rates of Phase II oncology trials2015/09/14English15
Comparing diagnostic tests on benefit-risk2016/08/22English15
Implications of chance baseline differences in repeated measurement designs1994/01/01English15
A two one-sided tests procedure for assessment of individual bioequivalence1997/01/01English15
Meta-analysis for bioequivalence review1997/01/01English15
Permutation Test Following Covariate-Adaptive Randomization in Randomized Controlled Trials2009/01/02English15
Fallback Tests in Dose-Response Clinical Trials2006/10/01English15
A Bayesian Design and Analysis for Dose-Response Using Informative Prior Information2006/10/01English15
Statistical Quality Control Process for Traditional Chinese Medicine2006/12/01English15
p-Value Calculation for Multistage Phase II Cancer Clinical Trials2006/12/01English15
On Power and Sample Size Calculation for QT Studies with Recording Replicates at Given Time Point2008/05/08English15
Power and Sample Size Calculation for Microarray Studies2011/12/28English15
Bayesian Assessment of the Influence and Interaction Conditions in Multipopulation Tailoring Clinical Trials2014/01/02English15
Power and Sample Size Determination in Clinical Trials with Multiple Primary Continuous Correlated Endpoints2014/03/04English15
Optimal Timing for Interim Analyses in Clinical Trials2013/08/19English15
Fractional Dose-Finding Methods with Late-Onset Toxicity in Phase I Clinical Trials2013/06/20English15